Literature DB >> 17348805

Identification of cord blood-derived mesenchymal stem/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles.

Vladimir Markov1, Kenro Kusumi, Mahlet G Tadesse, Dilusha A William, Dorian M Hall, Vitali Lounev, Arlene Carlton, Jay Leonard, Rick I Cohen, Eric F Rappaport, Biagio Saitta.   

Abstract

Phenotypic heterogeneity has been observed among mesenchymal stem/stromal cell (MSC) populations, but specific genes associated with this variability have not been defined. To study this question, we analyzed two distinct isogenic MSC populations isolated from umbilical cord blood (UCB1 and UCB2). The use of isogenic populations eliminated differences contributed by genetic background. We characterized these UCB MSCs for cell morphology, growth kinetics, immunophenotype, and potential for differentiation. UCB1 displayed faster growth kinetics, higher population doublings, and increased adipogenic lineage differentiation compared to UCB2. However, osteogenic differentiation was stronger for the UCB2 population. To identify MSC-specific genes and developmental genes associated with observed phenotypic differences, we performed expression analysis using Affymetrix microarrays and compared them to bone marrow (BM) MSCs. We compared UCB1, UCB2, and BM and identified distinct gene expression patterns. Selected clusters were analyzed demonstrating that genes of multiple developmental pathways, such as transforming growth factor-beta (TGF-beta) and wnt genes, and markers of early embryonic stages and mesodermal differentiation displayed significant differences among the MSC populations. In undifferentiated UCB1 cells, multiple genes were significantly up-regulated (p < 0.0001): peroxisome proliferation activated receptor gamma (PPARG), which correlated with adipogenic differentiation capacities, hepatocyte growth factor (HGF), and stromal-derived factor 1 (SDF1/CXCL12), which could both potentially contribute to the higher growth kinetics observed in UCB1 cells. Overall, the results confirmed the presence of two distinct isogenic UCB-derived cell populations, identified gene profiles useful to distinguish MSC types with different lineage differentiation potentials, and helped clarify the heterogeneity observed in these cells.

Entities:  

Mesh:

Year:  2007        PMID: 17348805     DOI: 10.1089/scd.2006.0660

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  32 in total

1.  Mesenchymal stem cells and their conditioned medium improve integration of purified induced pluripotent stem cell-derived cardiomyocyte clusters into myocardial tissue.

Authors:  Martin Rubach; Roland Adelmann; Moritz Haustein; Florian Drey; Kurt Pfannkuche; Bing Xiao; Annette Koester; Floris E A Udink ten Cate; Yeong-Hoon Choi; Klaus Neef; Azra Fatima; Tobias Hannes; Frank Pillekamp; Juergen Hescheler; Tomo Šarić; Konrad Brockmeier; Markus Khalil
Journal:  Stem Cells Dev       Date:  2014-01-15       Impact factor: 3.272

Review 2.  Cord blood--an alternative source for bone regeneration.

Authors:  Marcus Jäger; Christoph Zilkens; Bernd Bittersohl; Rüdiger Krauspe
Journal:  Stem Cell Rev Rep       Date:  2009-08-04       Impact factor: 5.739

3.  Phenotypic Characterization of Mesenchymal Stem Cells from Various Tissues.

Authors:  Markus Thomas Rojewski; Barbara Maria Weber; Hubert Schrezenmeier
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

4.  Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.

Authors:  Karen Bieback; Irena Brinkmann
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

5.  Expression of the filaggrin gene in umbilical cord blood predicts eczema risk in infancy: A birth cohort study.

Authors:  A H Ziyab; S Ewart; G A Lockett; H Zhang; H Arshad; J W Holloway; W Karmaus
Journal:  Clin Exp Allergy       Date:  2017-06-19       Impact factor: 5.018

6.  Dissection of the cord blood stromal component reveals predictive parameters for culture outcome.

Authors:  Mario Barilani; Cristiana Lavazza; Mariele Viganò; Tiziana Montemurro; Valentina Boldrin; Valentina Parazzi; Elisa Montelatici; Mariacristina Crosti; Monica Moro; Rosaria Giordano; Lorenza Lazzari
Journal:  Stem Cells Dev       Date:  2015-01-01       Impact factor: 3.272

7.  Patient-derived skeletal dysplasia induced pluripotent stem cells display abnormal chondrogenic marker expression and regulation by BMP2 and TGFβ1.

Authors:  Biagio Saitta; Jenna Passarini; Dhruv Sareen; Loren Ornelas; Anais Sahabian; Shilpa Argade; Deborah Krakow; Daniel H Cohn; Clive N Svendsen; David L Rimoin
Journal:  Stem Cells Dev       Date:  2014-04-01       Impact factor: 3.272

8.  Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells.

Authors:  Katie C Russell; H Alan Tucker; Bruce A Bunnell; Michael Andreeff; Wendy Schober; Andrew S Gaynor; Karen L Strickler; Shuwen Lin; Michelle R Lacey; Kim C O'Connor
Journal:  Tissue Eng Part A       Date:  2013-05-30       Impact factor: 3.845

9.  Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway.

Authors:  Venkata Ramesh Dasari; Kiranpreet Kaur; Kiran Kumar Velpula; Meena Gujrati; Daniel Fassett; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

10.  Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells.

Authors:  Letizia Penolazzi; Renata Vecchiatini; Stefania Bignardi; Elisabetta Lambertini; Elena Torreggiani; Alessandro Canella; Tiziana Franceschetti; Giorgio Calura; Fortunato Vesce; Roberta Piva
Journal:  Reprod Biol Endocrinol       Date:  2009-10-05       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.